Headache and Migraine
Zogenix Announces sumatriptan DosePro(TM) NDA Accepted for Filing by FDA
Published in Medical Letter on the CDC and FDA, April 6th, 2008
Zogenix, Inc. ("Zogenix"), a private, specialty pharmaceutical company, announced that its New Drug Application (NDA) for sumatriptan DosePro(TM) has been accepted for filing by the U.S. Food and Drug Administration (FDA). Zogenix is seeking marketing approval from the FDA of sumatriptan DosePro for the acute treatment of migraine attacks with or without aura and cluster headache episodes. The FDA will take action on its application in late 2008.
Sumatriptan DosePro (formerly known as Intraject(R) sumatriptan) utilizes Zogenix's proprietary DosePro needle-free drug delivery system to subcutaneously administer sumatriptan for the treatment of migraine and cluster...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Biopharmaceuticals
OMRIX Biopharmaceuticals Provides Update on its Fibrin Patch Product Candidate - Bone Research
New bone research reported from Yale University, Medical Department - Breast Cancer Screening
Findings in breast cancer screening reported from University of California - Breast Implants
Studies conducted at S.V.M. Maharaj et al on breast implants recently published - Cryotherapy
Recent findings in cryotherapy described by M.H. Gold and colleagues - Drug Delivery
FDA Classifies Medtronic's Physician Communication Related to Inflammatory Mass Formation from Intrathecal Drug Therapy - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
